A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms

INTRODUCTION: S47445 is a novel positive allosteric modulator of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptors that may emerge as a favorable candidate for the symptomatic treatment of cognitive and depressive disorders in patients suffering from Alzheimer's disease (AD) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Katy, Gouttefangeas, Sylvie, Bretin, Sylvie, Galtier, Stéphanie, Robert, Philippe, Holthoff-Detto, Vjera, Cummings, Jeffrey, Pueyo, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597919/
https://www.ncbi.nlm.nih.gov/pubmed/31297437
http://dx.doi.org/10.1016/j.trci.2019.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597919/
https://www.ncbi.nlm.nih.gov/pubmed/31297437
http://dx.doi.org/10.1016/j.trci.2019.04.002

Ejemplares similares